Oxford Science Enterprises plc 13D and 13G filings for Barinthus Biotherapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 10:00 am Purchase | 2021-12-31 | 13G | Barinthus Biotherapeutics plc BRNS | Oxford Science Enterprises plc | 8,797,770 25.220% | 8,797,770 (New Position) | Filing |